Peripheral Artery Disease

• FDA approval · 2014-06-12
  FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)

  FDA approved a supplemental application for clopidogrel bisulfate from Dr. Reddy's Laboratories Limited. This action confirms approval of th…

• FDA approval · 2014-06-11
  FDA Approved: CLOPIDOGREL — Supplemental Application (Aurobindo Pharma Limited)

  The FDA approved a supplemental application to authorize a generic clopidogrel bisulfate product from Aurobindo Pharma Limited.

• FDA approval · 2014-04-11
  FDA Approved: CLOPIDOGREL — Original Application (Amneal Pharmaceuticals LLC)

  The FDA approved Amneal Pharmaceuticals LLC's original application for clopidogrel, enabling a generic version of the antiplatelet medicatio…

• FDA approval · 2013-12-12
  FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)

  The FDA approved a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC.

• FDA approval · 2012-05-17
  FDA Approved: CLOPIDOGREL — Original Application (Aurobindo Pharma Limited)

  FDA approves Aurobindo Pharma Limited's Original Application for clopidogrel bisulfate, enabling a generic version of clopidogrel to be mark…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2012-04-18
  FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)

  FDA approval of a supplemental application for clopidogrel bisulfate submitted by Dr. Reddy's Laboratories Limited.

• FDA approval · 2012-03-09
  FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved Teva's supplemental application for Cilostazol, enabling the generic Cilostazol product to be marketed.

• FDA approval · 2008-08-29
  FDA Approved: CILOSTAZOL — Supplemental Application (Apotex Corp.)

  FDA approved a supplemental application for Cilostazol from Apotex Corp., authorizing the marketing of a generic cilostazol product.

• FDA approval · 2008-06-27
  FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for cilostazol filed by Teva Pharmaceuticals USA, Inc.

• FDA approval · 2008-03-10
  FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)

  FDA approves Chartwell RX, LLC's supplemental application for cilostazol (generic) under ANDA077021, enabling market authorization for a gen…

• FDA approval · 2008-03-10
  FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)

  FDA approved a supplemental application for cilostazol filed by Chartwell RX, LLC.

• FDA approval · 2008-01-14
  FDA Approved: CLOPIDOGREL BISULFATE — Original Application (Dr.Reddy's Laboratories Limited)

  FDA approved Dr. Reddy's Laboratories Limited's clopidogrel bisulfate tablet under an Original Application (ANDA076273). The approval enable…

• FDA approval · 2007-09-20
  FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)

  FDA approves a supplemental application for PLAVIX (clopidogrel) from Sanofi-Aventis U.S. LLC.

• FDA approval · 2007-08-16
  FDA Approved: CILOSTAZOL — Supplemental Application (Apotex Corp.)

  FDA approves a supplemental application for cilostazol submitted by Apotex Corp.

• FDA approval · 2006-12-07
  FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  The FDA approved a supplemental application for Cilostazol submitted by Teva Pharmaceuticals USA, Inc., related to the approved Cilostazol p…